A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis
Clinical trial NCT00239395 · COMPLETED
Trial details
- NCT number
- NCT00239395
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2004-12-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.